Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Godwin

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Leukemia|March 1, 1993
A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group studyL Elias, D Stock-Novack, D R Head, et al.
The Annals of Pharmacotherapy|September 12, 2000
A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillationR T Weibert, B F Yeager, A K Wittkowsky, et al.
Transfusion|October 19, 2001
Evidence-based recommendations for the use of WBC-reduced cellular blood componentsT A Ratko, J P Cummings, H A Oberman, et al.
Leukemia|June 23, 2012
Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG reportF Ostronoff, M Othus, P A Ho, et al.
Leukemia Research|June 27, 2000
A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617T R Chauncey, C Rankin, J E Anderson, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Leukemia|March 1, 1993
A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group studyL Elias, D Stock-Novack, D R Head, et al.
The Annals of Pharmacotherapy|September 12, 2000
A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillationR T Weibert, B F Yeager, A K Wittkowsky, et al.
Transfusion|October 19, 2001
Evidence-based recommendations for the use of WBC-reduced cellular blood componentsT A Ratko, J P Cummings, H A Oberman, et al.
Leukemia|June 23, 2012
Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG reportF Ostronoff, M Othus, P A Ho, et al.
Leukemia Research|June 27, 2000
A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617T R Chauncey, C Rankin, J E Anderson, et al.
Pageof 3